In most cases, skin cancer screenings is very time consuming. With this in mind, German scientists have developed a full body dermatological scanner intended to help doctors diagnose skin conditions in the future.
"The scanner delivers standard data for the evaluation of skin. At the same time, it improves documentation of the development every single conspicuous mole," says Dr. Christian Teutsch from the Fraunhofer IFF.
Basal Cell Cancer of the Skin
Basal cell cancer is a locally invading cancer. It often occurs on the face above a line joining the angle of the mouth and the ear lobe.
Advertisement
When the exam starts, the surface of the patient's skin is scanned from different positions and broken down into approximately one hundred individual scans. Such image documentation already exists. But the crucial point, however, is that the actual size and changes in growth cannot be clearly discerned solely on the bases of scans.
That is why the Dermascanner generates additional scanned 3D data, which are fused with the 2D scans, thus assigning a scale to every single pixel in the image. The experts are integrating several 3D sensors in the scanner so that this functions.
The scanner was developed by a joint initiative of the University Clinic for Dermatology and Venerology in Magdeburg, Dornheim Medical Images GmbH and Hasomed GmbH, Fraunhofer Institute for Factory Operation and Automation IFF.
Source: Medindia
The scanner was developed by a joint initiative of the University Clinic for Dermatology and Venerology in Magdeburg, Dornheim Medical Images GmbH and Hasomed GmbH, Fraunhofer Institute for Factory Operation and Automation IFF.
Source: Medindia
Epidermolysis Bullosa
People with epidermolysis bullosa (EB) develop skin blisters in response to minor injury. EB can occur in all racial and ethnic groups.
Advertisement
 MelanomaMelanoma of the skin is a dangerous type of skin cancer that usually appears as a cancerous mole due to exposure to the sun's damaging UV rays. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.